Molgramostim

Molgramostim is a synthetic, recombinant form of human granulocyte-macrophage colony-stimulating factor (GM-CSF). It is used to stimulate the production of white blood cells, which are essential for the body's immune response. Molgramostim is used in the treatment of neutropenia, a condition characterized by low levels of neutrophils, a type of white blood cell.

Mechanism of Action

Molgramostim works by stimulating the bone marrow to produce more white blood cells. It binds to specific receptors on the surface of hematopoietic progenitor cells, triggering a series of intracellular events that lead to the proliferation and differentiation of these cells into mature granulocytes and macrophages.

Clinical Uses

Molgramostim is used in the treatment of neutropenia, a condition characterized by low levels of neutrophils. It is also used to increase white blood cell counts in patients undergoing chemotherapy or bone marrow transplantation. In addition, it is used in the treatment of severe, chronic neutropenia.

Side Effects

Common side effects of molgramostim include bone pain, muscle aches, fever, and fatigue. Less common side effects include allergic reactions, fluid retention, and changes in blood pressure.

Contraindications

Molgramostim should not be used in patients with known hypersensitivity to the drug or any of its components. It should also be used with caution in patients with pre-existing heart disease, lung disease, or kidney disease.

See Also

• Granulocyte-macrophage colony-stimulating factor
• Neutropenia
• Chemotherapy
• Bone marrow transplantation

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia